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I@-Phenylisopropyladenosine wasemployed in the absence of endogenous adenosine to explore the 
influence xerted by the R-site over the antagonistic interaction of insulin and catecholamines on several 
parameters of fat cell metabolism. When no hormones were present, N6-phenylisopropyladenosine had 
little or no effect; however, the nucleoside potentiated insulin inhibition of catecholamine-stimulated 
events, such as lipolysis, and, conversely, diminished or blocked catecholamine inhibition of insulin- 
stimulated processes, uch as 2-deoxyglucose uptake, glucose oxidation and esterification, even under 
conditions where I@-phenylisopropyladenosine, alone, was ineffective in reversing catecholamine actions. 
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1. INTRODUCTION 2. EXPERIMENTAL 
Insulin and catecholamines generally exert op- 
posing actions on fat cell metabolism. The anti- 
lipolytic action of insulin is well documented 
(review [l]); however, the hormone has little effect 
when glycerol release from fat cells is stimulated by 
10e6 M norepinephrine, in the presence of 
adenosine deaminase [2-41. Adenosine and R-site 
analogues, such as N6-phenylisopropyladenosine 
(PIA), are also ineffective in inhibiting lipolysis 
stimulated by 10e6 M norepinephrine. A combina- 
tion of insulin and either adenosine or PIA, 
however, strongly inhibits catecholamine- 
stimulated glycerol release [2-41. This suggests a 
role for the R-site, under certain circumstances, in 
modulating the antagonistic interaction of insulin 
and catecholamines on lipolysis. These data in- 
dicate that the R-site exerts a similar influence over 
the opposing actions of insulin and catecholamines 
on fat cell hexose transport, glucose oxidation and 
esterification. 
Crude Clostridium histolyticum collagenase (EC 
3.4.24.3, lot 37C-6860), bovine serum albumin 
(BSA) (Cohn fraction V; lot 88C-0252), 
epinephrine, norepinephrine, insulin (bovine), and 
adenosine deaminase (ADA) were obtained from 
Sigma Chemicals (St Louis MO). All radioche- 
micals were purchased from Amersham (Arlington 
Heights IL). N6-(Phenylisopropyl)adenosine was a 
gift from Dr Harald Stork of Boehringer (Mann- 
heim) .
2.1. Treatment of rats and preparation of fat cells 
Male Wistar rats (180-200 g) were allowed free 
access to laboratory chow until the time of 
sacrifice. Rats were stunned by a blow to the head 
and killed by cervical dislocation. The epididymal 
fat pads were excised, washed in warm saline 
(37’C), minced and digested in a bicarbonate- 
buffered medium (KRB) (pH 7.4) containing 3% 
bovine serum albumin (BSA), glucose (2 mg/ml) 
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and collagenase (1 mglml) [5]. Liberated cells were 
filtered through a nylon mesh, washed twice in 
glucose-free medium, and resuspended in the buf- 
fer. Fat cell DNA was measured following the 
method in [6]. 
2.2. Measurement of lipolysis 
Cells were incubated in 2 ml KRB containing 
3% BSA at 37°C in a Dubnoff metabolic in- 
cubator. At the end of the incubation, aliquots of 
the medium were removed from beneath the 
floating layer of fat cells for the determination of 
glycerol and non-esterified fatty acids (NEFA). 
Glycerol, in deproteinized and neutralized 
samples, was assayed enzymatically by 
fluorimetric method in (71. Aliquots of medium, 
after extraction in Dole’s mixture 181, were assayed 
for NEFA, employing the calorimetric determina- 
tion in 191. 
2.3. Conversion of (i4CJglucose to 14COz and 
lipids 
Determination of [r4C]glucose oxidation has 
been described in [IO]. 
2.4. Glucose transport studies 
Glucose transport was measured as in [l I] using 
either D-3-O-methyl[14C]glucose or 2-D- 
deoxy[3H]glucose as substrate. A concentrated fat 
cell suspension (50 ~1) was preincubated with addi- 
tions for 15 min in Eppendorf microcentrifuge 
tubes. The reaction was initiated by rapid addition 
of 20~1 labeled sugar (3 nmol) to the fat cell 
suspension. Transport was terminated at the 
desired time by addition of buffer (0.4 ml) con- 
taining 0.3 mM phloretin. To correct for ex- 
tracellular trapping of water, uptake was measured 
in parallel incubations in the presence of 5OpM 
c~o~halasin B and subtracted from the other 
values obtained. Cells were then separated from 
the buffer by the oil-flotation technique [12] and 
removed with a piece of absorptive material into a 
scintillation vial and counted for 14C- or 3H- 
radioactivity. 
Radioactivity was measured in Aquasol using a 
Packard Tricarb Liquid Scintillation Spectrometer 
(Model 574). Quenching corrections were applied 
using the channel’s ratio method. 
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3. RESULTS AND DISCUSSION. 
The role of adenosine in modulating hormone 
action on fat cell metabolism was studied in rat 
adipocytes. The R-site analogue of adenosine, 
PIA, in the absence of endogenous adenosine, was 
used to explore this relationship. The antagonistic 
interaction of catecholamines, such as nor- 
epinephrine and epinephrine, and the polypeptide 
hormone, insulin, on hexose transport, glucose 
oxidation, glycerol release and NEFA re-esterifi- 
cation served as the model of hormone action. A 
role for adenosine in fat cell metabolism has been 
suggested, on one or more parameters [ 13-161. 
This work aimed to extend the study to several 
parameters, under identical conditions which con- 
trol for the level of endogenous adenosine in the 
cell [ 17,181. Maximally effective concentrations of 
PIA, insulin and catecholamines were employed 
throughout. 
A combination of epinephrine and insulin, in the 
presence of adenosine deaminase, stimulates 3-0- 
methylglucose (3-OMG) uptake 2-3-fold above 
basal values (fig.1). Inclusion of the R-site 
analogue, PIA, had no effect on 3-OMG transport 
induced by these two hormones (fig.1). In con- 
trast, PIA does reverse the effects of epinephrine 
in inhibiting basal and insulin-stimulated 
2-deoxyglucose (ZDG) transport in the presence of 
adenosine deaminase (table 1). PGEr, nicotinic 
acid and 2-deoxycoformycin, an inhibitor of 
adenosine deaminase, also reverse the effects of 
epinephrine on 2-DG transport (not shown). 
These results: (1) support the concept of dif- 
ferent regulatory processes for 2-DC and 3-OMG 
transport as suggested in [19,20]; (2) strongly im- 
plicate a role for the R-site in modulation of hex- 
ose transport as modified by hormonal treatment. 
PIA elicited a pattern of responses on 
[l-14C]glucose oxidation which was essentially 
similar to its effects on 2-DG uptake. The R-site 
analogue exerted its greatest effect on the com- 
bination effect of insulin plus norepinephrine 
(fig.2). In the presence of adenosine deaminase, 
norepinephrine strongly depressed glucose oxida- 
tion stimulated by insulin. However, when PIA 
was added, norepinephrine actually slightly 
enhanced the stimulation of glucose conversion to 
CO2 induced by insulin. Also the high Cr/Cs ratio 
(ratio of glucose carbon 1 to glucose carbon 6 ox- 
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Fig.1. The effect of PIA on 3-GMG uptake in the 
presence of insulin and epinephrine. Fat cells were 
incubated with epinephrine (1 PM) and insulin (3.3 nM) 
in the presence (0) and absence (A) of PIA (0.1 PM) for 
15 mitt at 37°C in KRB (3% BSA) containing ADA 
(2 pg/ml). Uptake was initiated by the forceful addition 
of 20 ,ul buffer containing 3-O-methyl[14C]glucose 
(3 nmol, 0.2&i) and terminated at the indicated times 
as in section 2. The results are presented as the means of 
3 duplicated expts. The discontinuous line represents 
3-OMG uptake in the absence of other additions 
(+ ADA). 
Table 1 
The effect of PIA, epinephrine and insulin on 2-DG 
uptake in isolated fat cells 
Addition (-) (+ )PIA 
None 2.046 + 0.321 2.913 f 0.328 
Insulin 5.599 + 0.532 5.711 f 0.742 
Epinephrine 1.011 + 0.271 2.480 + 0.381 
Insulin + epinephrine 3.647 + 0.675 6.064 J- 0.626 
The conditions employed for the measurement of hexose 
transport are described in section 2. insulin (3.3 nM), 
epinephrine (1 FM) and PIA (0.1 PM) were included, 
where indicated, together with adenosine deaminase 
(2pg/ml). The results are expressed in nmol/lOOpg. 
DNA and represent he means -+ SEM of 3 duplicated 
expts 
idized), indicative of the quantity of glucose pro- 
cessed via the pentose phosphate shunt, observed 
with insulin, was lowered by norepinephrine; the 
lowering effect of catecholamine on the insulin- 
enhanced G/C6 ratio was partially reversed by 
PIA. 
Modulation by PIA of the antagonistic interac- 
tion of catecholamine and insulin on glycerol 
release was reported in [2-41, and these results ex- 
tend those findings (fig.3). Our results indicate 
that not only is insulin inhibition of 
catecholamine-stimulated lipolysis influenced by 
PIA, but also the efficacy with which insulin 
stimulates re-esterification of liberated non- 
esterified fatty acids (NEFA) (fig.3). PIA slightly 
stimulated the removal by fat cells of NEFA from 
the incubation medium. This effect of PIA was 
potentiated in the presence of glucose (10 mM). In- 
sulin (3.3 nM) also slightly stimulated NEFA 
removal from the incubation medium and again 
this effect of the hormone was enhanced by 
F (+)PIA 
I.49 
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Fig.2. The effect of insulin, norepinephrine and PIA on 
]l-14C]glucose and [6-‘4C]glucose conversion to ‘%ZOs. 
Fat cells were incubated in KRB containing BSA (3Yo), 
ADA (2pg/ml) with [I-‘4C]glucose (open bars) or 
[6-i4C]glucose (shaded bars) (5 mM, 0.2&i) for 1 h at 
37°C. Insulin (3.3 nM), norepinephrine (1 PM) and PIA 
(0.1 PM) were included where indicated. The values 
appearing above the histograms are the Ct/Ca ratio. The 
results are presented as means of 3 duplicated expts. 
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Fig.3. The effect of insulin and glucose on basal and 
epinephrine-stimulated glycerol and NEFA release in the 
presence and absence of PIA. Fat cells were incubated 
for 1 h at 37°C in KRB containing BSA (3010), ADA 
(2 pg/ml) and, where indicated, norepinephrine (1 PM), 
glucose (10 mM), insulin (3.3 nM) and PIA (0.1 pM). 
For both glycerol and NEFA, the zero time value (i.e., 
the value of samples taken immediately after addition of 
suspended cells to the incubation medium) was 
subtracted from the final value to give the release rate 
per hour. The BSA used (Sigma, lot 88C-0254) 
contained 14.5 pmol NEFA/g (molar ratio NEFA : BSA 
0.87). The results represent the means + SEM of 3 
duplicated expts. 
glucose. PIA and insulin, when added alone, had 
little effect on norepinephrine-stimulated NEFA 
liberation; however, as with glycerol release, a 
combination of the two agents elicited a strong in- 
hibitory effect (fig.3). In the presence of glucose, 
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the inhibition of norepinephrine-stimulated NEFA 
release caused by PIA and insulin was greatly 
enhanced, although the sugar had no measurable 
effect on glycerol release. Glucose probably in- 
creased re-esterification of released NEFA by fur- 
nishing a source of a-glycerophosphate. 
On several parameters of fat cell metabolism the 
pattern of responses elicited by PIA is similar. PIA 
is generally only weakly effective in the absence of 
hormones; however, the nucleoside potentiates in- 
sulin inhibition of catecholamine-stimulated 
events, such as lipolysis, and, conversely, reduces 
or blocks catecholamine inhibition of insulin 
stimulated processes, such as 2-DG transport, 
[l-14C]glucose oxidation and esterification, even 
under conditions where PIA alone is ineffective in 
reversing catecholamine actions. The mechanism 
by which PIA modulates the antagonistic interac- 
tion of insulin and catecholamines awaits further 
study. 
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